Neuronetics (STIM) Live Share Price, Invest From India

Neuronetics Stock Performance

as on November 5, 2026 at 6:09 am IST

Day's Low
Day's High
$2.55
Day's Price Range
$3.05
$2.79
8.60%
Downside
9.32%
Upside
52 Week's Low
52 Week's High
$0.80
52-Week Price Range
$3.44
$2.79
71.33%
Downside
23.30%
Upside

Neuronetics share price movements today

Previous Close: $2.26
Open: $2.77
Volume: 3.5M
Market Cap: $171.4M
Day's Low - High: $2.55 - $3.05
52 Week Low - High: $0.80 - $3.44

Neuronetics Historical Returns

1 Month Return: -4.63 %
3 Month Return: -4.63 %
1 Year Return: -25.63 %
3 Year Return: + 47.14 %
5 Year Return: -62.48 %

Neuronetics Stock Fundamentals & Key Indicators

Check Neuronetics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$171.4M

EPS (TTM)

-0.43

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.23

Industry PE ratio

-4.56

PEG Ratio

-0.05

EBITDA

-19.8M

Revenue (TTM)

155.1M

Profit Margin

49.12%

Return On Equity TTM

-150.56%

Neuronetics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neuronetics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Neuronetics	Buy	$171.4M	-62.48%	-5.23	49.12%	0.00%
Edwards Lifesciences	StrongBuy	$53.0B	-20.46%	52.88	77.98%	0.00%
Medtronic	Buy	$123.5B	-18.06%	23.60	66.69%	2.96%
Abbott Laboratories	StrongBuy	$183.8B	-16.84%	39.33	57.12%	2.37%
Stryker	StrongBuy	$111.9B	7.05%	30.88	65.52%	1.21%

See all

Stock Returns calculator for Neuronetics Stock including INR - Dollar returns

The Neuronetics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Neuronetics investment value today

Current value as on today

₹1,07,428

Returns

₹7,428

(+7.43%)

Returns from Neuronetics Stock

₹722 (+0.72%)

Dollar Impact

₹6,706 (+6.71%)

Analyst Recommendation on Neuronetics Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Neuronetics. Average target price of $5.75

Neuronetics Share Price Target

Get share price movements and forecasts by analysts on Neuronetics.

What analysts predicted

51.48%UPSIDE

Target Price

$5.75

Current Price

$2.79

Analyzed by

2 Analysts

High

Target

$5.75

Low

Neuronetics target price $5.75, a slight upside of 51.48% compared to current price of $2.79. According to 2 analysts rating.

Indian Investors' Interest in Neuronetics Stock

Search interest for Neuronetics Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 6, 2026 to November 5, 2026

Change:-50% versus previous 30 day period

Neuronetics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	17	16	18	22	31	38	37	41	34	41
Gross Profit	13	12	14	14	15	17	17	21	16	21
Operating Income	-6	-8	-7	-11	-11	-8	-7	-5	-8	-1
EBITDA	-5	-7	-11	-10	-9	-7	-6	-4	-7	-1
Interest Expense	1	1	1	1	1	1	2	2	2	2
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-9	-13	-12	-12	-9	-9	-7	-10	-3
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-7	-9	-13	-12	-12	-10	-9	-7	-10	-3
Net Profit Margin	75.14%	74.04%	75.56%	66.21%	49.22%	46.60%	45.87%	51.95%	46.89%	51.06%

Neuronetics Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	40	52	62	49	55	65	71	74	149
Gross Profit	30	40	47	37	43	49	51	54	72
Operating Income	-13	-19	-26	-22	-27	-35	-30	-34	-31
EBITDA	-12	-19	-27	-25	-26	-31	-22	-34	-27
Interest Expense	2	3	3	4	3	3	5	7	8
Depreciation	0	0	1	0	1	1	2	2	3
Income Before Tax	-16	-24	-29	-27	-31	-37	-30	-43	-38
Income Tax Expense	-	-	-	-	-	-	0	0	-
Net Income	-16	-24	-29	-27	-31	-37	-30	-43	-38
Net Profit Margin	76.18%	76.42%	75.44%	76.54%	78.93%	76.26%	72.47%	72.32%	48.48%

Neuronetics Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-7	-9	-13	-12	-12	-10	-9	-7	-10	-3
Operating Cash Flow	-12	-4	-5	-8	-16	-3	0	0	-9	0
Investing Cash Flow	0	0	0	-2	0	0	0	0	0	0
Financing Cash Flow	-	-	-16	9	18	0	17	-1	-5	15
Change in Cash	-11	-5	-21	-1	1	-3	17	0	-15	15

Neuronetics Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-16	-24	-29	-27	-31	-37	-30	-43	-39
Operating Cash Flow	-11	-20	-30	-28	-27	-30	-32	-30	-20
Investing Cash Flow	0	-1	0	0	-9	6	-1	-2	0
Financing Cash Flow	23	97	2	2	83	0	22	-6	35
Change in Cash	12	75	-28	-26	45	-23	-10	-40	14

Global Institutional Holdings in Neuronetics

Check out the Institutions with significant holdings in Neuronetics.

Funds	Holdings
Chernett Jorey	13.92%
Madryn Asset Management, LP	2.98%
Sasha Cucuz	2.70%
Charles Davidson	2.63%
Keith Sullivan	2.09%

See all

Insights on Neuronetics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 34.45M → 41.56M (in $), with an average increase of 17.1% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -10.79M → -3.43M (in $), with an average increase of 213.8% per quarter
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, STIM has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 1 month, STIM stock has moved up by 4.6%
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp has given 13.1% return, outperforming this stock by 34.4%

About Neuronetics

Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.

Organisation	Neuronetics
Headquarters	3222 Phoenixville Pike, Malvern, PA, 19355, US
Industry	Medical - Devices
CEO	Daniel L. Reuvers

Key Management of Neuronetics

Name	Title
Mr. Daniel L. Reuvers	CEO, President & Director
Mr. Nir Naor C.F.A., CPA, L.L.M., M.B.A.	Executive VP, CFO, Corporate Secretary, Principal Financial and Accounting Officer & Treasurer
Mr. Robert Greene	Senior Vice President of Sales
Mr. Cory S. Anderson	Executive Vice President & General Manager of Greenbrook

FAQs

What is Neuronetics share price today?

Neuronetics share price today is $2.79 as on November 5, 2026 at 12:39 am IST. Neuronetics share today touched a day high of $3.05 and a low of $2.55.

What is the 52 week high and 52 week low for Neuronetics share?

Neuronetics share touched a 52 week high of $3.44 on August 12, 2026 and a 52 week low of $0.80 on March 17, 2026. Neuronetics stock price today i.e. November 5, 2026 at 12:39 am IST is trending at $2.79,which is 18.90% down from its 52 week high and 248.75% up from its 52 week low.

What is Neuronetics's market capitalisation today?

Neuronetics market capitalisation is $0.00T as on November 5, 2026 at 12:39 am IST.

How to invest in Neuronetics Stock (STIM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Neuronetics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Neuronetics Stock (STIM) from India?

Indian investors can start investing in Neuronetics (STIM) shares with as little as ₹94.63999938964844 or $1 (as of November 5, 2026 at 12:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.40 in Neuronetics stock (as per the Rupee-Dollar exchange rate as on November 5, 2026 at 12:39 am IST). Based on Neuronetics share’s latest price of $2.79 as on November 5, 2026 at 12:39 am IST, you will get 3.5842 shares of Neuronetics. Learn more about fractional shares .

What are the returns that Neuronetics has given to Indian investors in the last 5 years?

Neuronetics stock has given -62.48% share price returns and 27.31% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?